New Online

This multi-institutional nonrandomized clinical trial testing a novel diagnostic/screening assay aims to determine whether soluble CD44 and total protein are useful for monitoring head and neck cancer recurrence, either used in a point-of-care test or as individual laboratory-based biomarkers.

A 67-year-old patient presented with persistent vertigo and pulsatile tinnitus in the left ear for the past 3 months, and 5 days after treatment he experienced acute hearing loss of the left ear and vertigo. What is your diagnosis?

This cohort study examines the clinical association between cannabis use and head and neck cancer.

This prospective observational pilot study examines the safety and feasibility of planned dental extractions in the immediate postradiation timeframe for patients with previously untreated cancers of the head and neck undergoing radiation therapy.

This survey study examines oral and dental complications of cancer treatment among patients with head and neck cancer, the association of cancer treatment with dental care use, and costs of associated dental treatment.

This secondary cohort analysis identifies clinical predictors of patient response to cognitive behavioral therapy for the treatment of tinnitus.